These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11489676)

  • 21. Early-onset autosomal-recessive parkinsonian-pyramidal syndrome.
    Lai HJ; Lin CH; Wu RM
    Acta Neurol Taiwan; 2012 Sep; 21(3):99-107. PubMed ID: 23196729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rapid-onset dystonia-parkinsonism].
    Zaremba J
    Przegl Lek; 2005; 62(11):1296-7. PubMed ID: 16512624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinsonism and dystonia: Clinical spectrum and diagnostic clues.
    Morales-Briceno H; Fung VSC; Bhatia KP; Balint B
    J Neurol Sci; 2022 Feb; 433():120016. PubMed ID: 34642024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pallidal Deep-Brain Stimulation Disrupts Pallidal Beta Oscillations and Coherence with Primary Motor Cortex in Parkinson's Disease.
    Wang DD; de Hemptinne C; Miocinovic S; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    J Neurosci; 2018 May; 38(19):4556-4568. PubMed ID: 29661966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel SERAC1 mutations in a Chinese patient presenting with parkinsonism and dystonia.
    Ma J; Wang L; Yang YM; Mao CH; Wan XH
    Neurol Sci; 2018 May; 39(5):967-969. PubMed ID: 29332177
    [No Abstract]   [Full Text] [Related]  

  • 27. Dystonia-parkinsonism disease gene discovery: expect surprises.
    Hayflick SJ
    Ann Neurol; 2009 Jan; 65(1):2-3. PubMed ID: 19194873
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of PLA2G6 as a locus for dystonia-parkinsonism.
    Paisan-Ruiz C; Bhatia KP; Li A; Hernandez D; Davis M; Wood NW; Hardy J; Houlden H; Singleton A; Schneider SA
    Ann Neurol; 2009 Jan; 65(1):19-23. PubMed ID: 18570303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Botulinum neurotoxin efficiency in dystonia associated with Parkinson's disease and atypical parkinsonism: a retrospective study with a self-reported improvement scale.
    Lapostolle A; Houot M; Mongin M; Degos B
    J Neurol; 2022 Nov; 269(11):6021-6028. PubMed ID: 35854137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
    Friedman JH; Factor SA
    Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fracture risk associated with parkinsonism and anti-Parkinson drugs.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2007 Sep; 81(3):153-61. PubMed ID: 17705047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinsonism and dystonia are differentially induced by modulation of different territories in the basal ganglia.
    Kumbhare D; Holloway KL; Baron MS
    Neuroscience; 2017 Jun; 353():42-57. PubMed ID: 28412499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).
    Lew MF; Shindo M; Moskowitz CB; Wilhelmsen KC; Fahn S; Waters CH
    Mov Disord; 1994 May; 9(3):318-20. PubMed ID: 8041372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Craniocervical dystonia with levodopa-responsive parkinsonism co-segregating with a pathogenic ANO3 mutation in a Taiwanese family.
    Kuo MC; Lin HI; Lin CH
    Parkinsonism Relat Disord; 2019 May; 62():236-238. PubMed ID: 30692049
    [No Abstract]   [Full Text] [Related]  

  • 35. Infantile parkinsonism-dystonia due to dopamine transporter gene mutations: another genetic twist.
    Blackstone C
    Lancet Neurol; 2011 Jan; 10(1):24-5. PubMed ID: 21112252
    [No Abstract]   [Full Text] [Related]  

  • 36. [Parkinson's Disease with Intolerable Painful Dystonia: Classification and Therapeutic Choices of Pain in Parkinson' Disease].
    Kajiyama Y; Mochizuki H
    Brain Nerve; 2022 May; 74(5):462-467. PubMed ID: 35589632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A; Miyatake T
    Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel compound heterozygous synaptojanin-1 mutation causes l-dopa-responsive dystonia-parkinsonism syndrome.
    Rauschendorf MA; Jost M; Stock F; Zimmer A; Rösler B; Rijntjes M; Piroth T; Coenen VA; Reinacher PC; Meyer PT; Frings L; Weiller C; Fischer J; Klebe S
    Mov Disord; 2017 Mar; 32(3):478-480. PubMed ID: 27869329
    [No Abstract]   [Full Text] [Related]  

  • 39. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease.
    Pouclet H; Derkinderen P; Lebouvier T
    Clin Neurol Neurosurg; 2013 Feb; 115(2):235-6. PubMed ID: 22743235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.